CELG

Celgene
127.45 USD
-3.6 -2.747%
1m
5m
15m
30m
1H
4H
1D
1W
  • Full Name Celgene
  • Currency USD
  • Spread Type Floating
  • Margin 10%
  • Min traded quantity 10
  • Trading hours Mon - Fri 13:30 - 20:00 (UTC)
  • Long position overnight fee -0.0145%
  • Short position overnight fee -0.0077%
  • Overnight fee time 00:00 AM
  • Derivative Type Contract for Difference

Celgene

Celgene Corporation (CELG) is the US biotech company that specializes in the discovery, production and marketing of medicines for cancer treatment and inflammatory diseases. The company’s flagship product is Revlimid, a medicine designed to treat myeloma. Apart from Revlimid, Celgene has a portfolio of products to offer including Vidaza, OTEZLA, ISTODAX and others. Most products developed by the Celgene Corporation consist of ImiDs compounds that boast highly important properties. Celgene Corp is listed on the NASDAQ stock exchange and constitutes the NASDAQ-100 index.
Ready to get started?
Send me the link to download Capital.com app. Download Capital.com